The present invention provides specific, selective and irreversible inhibitors and activity-based probes (ABPs) of KLK7. These ABPs and inhibitors are useful as new treatments for skin desquamating and/or inflammatory disorders, as new antiinflammatory agents, new anti-neurodegenerative agents and as new anticancer therapeutics. Also provided are pharmaceutical combinations of the compounds according to the invention with inhibitors of KLK5 for use in the treatment of said diseases and disorders. The invention also provides cosmetic compositions for skin application, preferably for the improvement of an undesirable skin condition. The compounds of the present invention can also be used for the in vitro and in vivo molecular diagnosis of skin disorders characterized by abnormal desquamation and/or inflammation, inflammatory diseases, neurodegenerative diseases or cancer.
本发明提供了KLK7的特异性、选择性和不可逆
抑制剂和活性基团探针(ABPs)。这些ABPs和
抑制剂可作为治疗皮肤脱屑和/或炎症性疾病的新疗法,新的抗炎药物,新的抗神经退行性药物以及新的抗癌治疗药物。本发明还提供了根据本发明的化合物与KLK5的
抑制剂的药物组合,用于治疗上述疾病和疾病。本发明还提供了用于皮肤应用的化妆品组合,优选用于改善不良皮肤状况。本发明的化合物还可用于体外和体内分子诊断具有异常脱屑和/或炎症、炎症性疾病、神经退行性疾病或癌症特征的皮肤疾病。